on 26 May 2022
Last Applicant/ Owned by
ENHANC3D GENOMICS LTD
Babraham Institute Building 570, Babraham Research Campus
Cambridge, , CB22 3AT
Serial Number
UK00003792376 filed on 26th May 2022
Registration Number
UK00003792376 registered on
26th Aug 2022
Correspondent Information
Basck Limited
9 Hills Rd
Cambridge,
CB2 1GE
Downloadable software; Downloadable software in the field of drug discovery; Downloadable software in the field of medical diagnosis; Downloadable software in the field of biomarker discovery; Downloadable software in the field of genomics; Downloadable software in the field of bioinformatics; Downloadable software for visualisation, analysis, and manipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Downloadable software in the field of data analysis, data processing, database management; Downloadable software for creating searchable databases of information and data; Downloadable software in the field of artificial intelligence, machine learning; Scientific research apparatus and instruments; Electronic databases; Downloadable publications; Downloadable publications in the field of drug discovery; Downloadable publications in the field of medical diagnosis; Downloadable publications in the field of biomarker discovery; Downloadable publications in the field of genomics; Downloadable publications in the field of bioinformatics.
Data analysis; Data analysis in the field of drug discovery; Data analysis in the field of medical diagnosis; Data analysis in the field of biomarker discovery; Data analysis in the field of genomics; Data analysis in the field of bioinformatics; Data processing; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and reporting services; Business information services; Business consulting services; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Business consulting services in the field of genomics; Market intelligence services; Collection of data; Compilation of data for use in scientific research; Information, advisory and consultancy services in relation to all of the aforesaid.
Software as a service (SaaS); Software as a service (SaaS) in the field of drug discovery; Software as a service (SaaS) in the field of medical diagnosis; Software as a service (SaaS) in the field of biomarker discovery; Software as a service (SaaS) in the field of genomics; Software as a service (SaaS) in the field of bioinformatics; Software as a service (SaaS) for visualisation, analysis, and manipulation of biological molecules; Software as a service (SaaS) for modelling and prediction of biological interactions; Software as a service (SaaS) for genome sequencing; Software as a service (SaaS) in the field of data analysis, data processing, database management; Software as a service (SaaS) in the field of artificial intelligence, machine learning; Platform as a service (PaaS); Platform as a service (PaaS) in the field of drug discovery; Platform as a service (PaaS) in the field of medical diagnosis; Platform as a service (PaaS) in the field of biomarker discovery; Platform as a service (PaaS) in the field of genomics; Platform as a service (PaaS) in the field of bioinformatics; Platform as a service (PaaS) for visualisation, analysis, and manipulation of biological molecules; Platform as a service (PaaS) for modelling and prediction of biological interactions; Platform as a service (PaaS) for genome sequencing; Platform as a service (PaaS) in the field of data analysis, data processing database management; Platform as a service (PaaS) in the field of artificial intelligence, machine learning; Design and development of software; Design and development of software in the field of drug discovery; Design and development of software in the field of medical diagnosis; Design and development of software in the field of biomarker discovery; Design and development of software in the field of genomics; Design and development of software in the field of bioinformatics; Design and development of software for visualisation, analysis, and manipulation of biological molecules; Design and development of software for modelling and prediction of biological interactions;Design and development of software for genome sequencing; Design and development of software in the field of data analysis; data processing, database management; Design and development of software in the field of artificial intelligence, machine learning; Scientific research services; Scientific research services in the field of drug discovery; Scientific research services in the field of medical diagnosis; Scientific research services in the field of biomarker discovery; Scientific research services in the field of genomics; Scientific research services in the field of bioinformatics; Scientific consulting services; Scientific consulting services in the field of drug discovery; Scientific consulting services in the field of medical diagnosis; Scientific consulting services in the field of biomarker discovery; Scientific consulting services in the field of genomics; Scientific consulting services in the field of bioinformatics; Scientific testing services; Scientific testing services in the field of drug discovery; Scientific testing services in the field of medical diagnosis; Scientific testing services in the field of biomarker discovery; Scientific testing services in the field of genomics; Scientific testing services in the field of bioinformatics; Data as a service (DaaS); Computer services for the analysis of data; Providing temporary use of non-downloadable software; Information, advisory and consultancy services in relation to all of the aforesaid.
UK00003792376
Word
Individual